Idera Pharmaceuticals Announces Retirement of Dr. James B. Wyngaarden as a Member of the Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that Dr. James B. Wyngaarden has chosen to retire from the Company’s Board of Directors after 21 years of dedicated service. Dr Wyngaarden was a founding Board member of Idera and has served in various capacities, including Chairman of the Board. “It has been my honor and pleasure to work with Jim for more than two decades,” said Sudhir Agrawal, D.Phil., Chairman and Chief Executive Officer of Idera. “T

Feed Date: 
February 17, 2012